PCSA
What one share of Processa Pharmaceuticals holds
Pharmaceutical Preparations
Processa Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$5.59 |
|---|---|
| Cash and investments | $0.07 |
| Book value | −$0.11 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$353.05 | — | −$347.69 | — | $877.92 |
| 2019 | — | −$349.71 | — | −$248.85 | — | $730.19 |
| 2020 | — | −$1,269 | — | −$209.56 | — | $808.77 |
| 2021 | $0.00 | −$372.97 | — | −$284.52 | — | $811.10 |
| 2022 | $0.00 | −$851.18 | — | −$298.12 | — | $232.94 |
| 2023 | — | −$211.99 | $0.05 | −$153.75 | — | $96.99 |
| 2024 | — | −$96.78 | $0.03 | −$91.87 | — | $11.45 |
| 2025 | — | −$10.36 | — | −$8.70 | — | $2.17 |